Mon, 13 March 2017
On today’s DiabetesPowerShow, Charlie Cherry, Chris Daniel, and Lori Cherry talk about alternate site testing. How can we lessen or eliminate the pain associated with finger sticks? To help us with that question, we welcome Dr. Christopher Jacobs, the CEO and Chief Research Engineer for Genteel. He promises that the Genteel Lancing Device will challenge everything you’ve come to believe about a lancing device.
During the show, Charlie, for the first time, successfully accomplished alternate site testing, using the Genteel device. The camera clicked, as he learned that this new lancing device allows you to poke your skin once, and return to the same spot throughout the day, and draw blood without actually piercing your skin again. The unit creates a vacuum, so you can flip the lancet in the device (the sharp part) away from the skin, and do multiple blood draws from just one poke. He successfully drew blood 4 times during the show, but only stuck himself once...Charlie is now a fan of the Genteel.
Dr. Christopher Jacobs is the Chief Research Engineer in the development of Genteel, and holder of 75 United States and international patents; new medical devices and instrumentation through Oregon Graduate Institute (OGI) and Oregon Health & Science University (OHSU). Biomedical engineer, designed and assisted in patenting world’s first variable rate cardiac pacemaker; Advanced Medical Technology (AMTEK), 1969, patented. Developed Control Systems for Artificial Kidneys (Renal Clearance); University of Southern California, 1964-1965.